INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹66 Cr | ₹66 Cr | ₹1.36 Cr | ₹4.24 Cr | ₹36 Cr |
What is the latest Contingent Liabilities ratio of INDSWIFT LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹66 Cr |
| Mar2025 | ₹66 Cr |
| Mar2024 | ₹1.36 Cr |
| Mar2023 | ₹4.24 Cr |
| Mar2022 | ₹36 Cr |
How is Contingent Liabilities of INDSWIFT LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹66 Cr | -0.11 | |
| Mar2025 | ₹66 Cr | 4,804.35 | |
| Mar2024 | ₹1.36 Cr | -68.05 | |
| Mar2023 | ₹4.24 Cr | -88.11 | |
| Mar2022 | ₹36 Cr | - | |
Compare Contingent Liabilities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹2,897.8 Cr | -8.7% | -19.2% | 229.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | -8.7% |
-19.2% |
229.7% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses